Drug giant Eli Lilly has announced a $35 cap on the monthly insulin costs in the US, cutting the price for popular insulins by 70%, reports BBC.
More than eight million Americans use insulin to control their diabetes, according to the American Diabetes Association.
Last year, the US passed a law capping monthly costs at $35 for people with certain government health insurance.